p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms

Area of Science:

• Molecular Biology
• Developmental Biology
• Cancer Research

Background:

• p19 Arf is a known tumor suppressor involved in cell cycle regulation.
• Its role in blocking platelet-derived growth factor receptor β (Pdgfrβ) signaling during eye development was previously unclear.
• Aberrant Pdgfrβ signaling is implicated in various developmental abnormalities.

Purpose of the Study:

• To elucidate the mechanisms by which p19 Arf regulates Pdgfrβ expression during mouse eye development.
• To investigate the roles of p53-dependent and -independent pathways in this regulation.
• To understand how p19 Arf controls pericyte proliferation and vascular remodeling.

Main Methods:

• Analysis of Arf knockout mouse models during embryonic development.
• In vitro studies using cultured fibroblasts and pericyte-like cells.
• Gene expression analysis (mRNA and protein levels) of Pdgfrβ.
• Reporter assays to assess promoter activity.
• Investigation of p53's role in Pdgfrβ regulation.

Main Results:

• Loss of Arf in developing eyes leads to pericyte hyperplasia due to enhanced Pdgfrβ-dependent proliferation.
• Arf deficiency increases Pdgfrβ expression at both mRNA and protein levels.
• p19 Arf represses Pdgfrβ transcription and protein synthesis via p53-dependent and -independent pathways.
• p53 is necessary for p19 Arf to fully regulate Pdgfrβ mRNA, but p19 Arf can inhibit protein synthesis independently of p53.

Conclusions:

• p19 Arf plays a critical role in controlling Pdgfrβ expression during eye development.
• This regulation occurs through novel mechanisms involving both transcriptional repression and inhibition of protein synthesis.
• These findings highlight a new function for p19 Arf in ensuring proper vascular remodeling for normal vision.